Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Apogee Biotechnology Corporation has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. The prosecution involves 1 distinct examiner and is located within 1 distinct art unit. This represents a highly focused and singular prosecution effort for the company's current filings. The presence of 1 distinct art unit suggests that the subject matter is concentrated within a specific technical field at the patent office.
NOTTINGHAM, KYLE GREGORY is the busiest examiner for the portfolio, managing the 1 pending office action. With only 1 distinct examiner and 1 distinct art unit, the applicant's current interactions with the patent office are centralized. This structure simplifies the management of the pending matter but relies entirely on the perspective of a single examiner within a specific art unit. The fact that 1 distinct examiner is responsible for the 1 pending office action allows for a targeted prosecution strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19045439 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF OBESITY AND OBESITY-INDUCED DISEASE | NOTTINGHAM, KYLE GREGORY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19045439 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF OBESITY AND OBESITY-INDUCED DISEASE | NOTTINGHAM, KYLE GREGORY | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19045439 | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF OBESITY AND OBESITY-INDUCED DISEASE | NOTTINGHAM, KYLE GREGORY | 1621 | §102§103§112 | Non-Final OA | — | Pending | Feb 04, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial